- Report
- August 2021
Global
From €3631EUR$3,990USD£3,113GBP
- Report
- August 2021
Global
From €3631EUR$3,990USD£3,113GBP
- Report
- February 2021
Global
From €2694EUR$2,960USD£2,309GBP
- Report
- February 2021
Global
From €2694EUR$2,960USD£2,309GBP
- Report
- February 2021
Global
From €2694EUR$2,960USD£2,309GBP
- Report
- February 2021
Global
From €2694EUR$2,960USD£2,309GBP
- Report
- November 2022
- 103 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Clinical Trials
- December 2021
- 1197 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Clinical Trials
- March 2024
- 1168 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- December 2023
- 180 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- December 2023
- 80 Pages
Vietnam
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1365EUR$1,500USD£1,170GBP
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
Russia
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
Poland
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
Japan
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
Ireland
From €1365EUR$1,500USD£1,170GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more